Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice

eLife

Volumn 2014, Issue 3, 2014, Pages

  Heckman, Laura Dean ^a,b   Chahrour, Maria H ^c   Zoghbi, Huda Y ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Jan and Dan Duncan Neurological Research Institute   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C TERMINAL TRANSCRIPTIONAL REPRESSION DOMAIN; CHROMATIN IMMUNOPRECIPITATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE DUPLICATION; GENE MUTATION; GENOTYPING TECHNIQUE; IMMUNOFLUORESCENCE TEST; LEARNING; MALE; MEMORY; MOTOR DYSFUNCTION; MOUSE; N TERMINAL METHYL CPG BINDING DOMAIN; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN DOMAIN; RETT SYNDROME; SURVIVAL; TRANSGENIC MOUSE; WESTERN BLOTTING;

EID: 84904976180     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.02676.001     Document Type: Article

References (33)

1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics 23:127-128. doi: 10.1038/13810.
2. Baker SA, Chen L, Wilkins AD, Yu P, Lichtarge O, Zoghbi HY. 2013. An at-hook domain in MeCP2 determines the Clinical course of rett syndrome and Related disorders. Cell 152:984-996. doi: 10.1016/j.cell.2013.01.038.
3. Ben-Shachar S, Chahrour M, Thaller C, Shaw CA, Zoghbi HY. 2009. Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Human Molecular Genetics 18:2431-2441. doi: 10.1093/hmg/ddp181.
4. Carney RM, Wolpert CM, Ravan SA, Shahbazian M, Ashley-Koch A, Cuccaro ML, Vance JM, Pericak-Vance MA. 2003. Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatric Neurology 28:205-211. doi: 10.1016/S0887-8994(02)00624-0.
5. Chahrour M, Jung SY, Shaw C, Zhou X, Wong STC, Qin J, Zoghbi HY. 2008. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320:1224-1229. doi: 10.1126/science.1153252.
6. Chahrour M, Zoghbi HY. 2007. The Story of rett syndrome: from Clinic to Neurobiology. Neuron 56:422-437. doi: 10.1016/j.neuron.2007.10.001.
7. Chao H-T, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu H-C, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY. 2010. Dysfunction in GABA signalling mediates austism-like stereotypies and Rett syndrome phenotypes. Nature 468:263-269. doi: 10.1038/nature09582.
8. Christodoulou J, Grimm A, Maher T, Bennetts B. 2003. RettBASE: the IRSA MECP2 variation database - a new mutation database in evolution. Human Mutation 21:466-472. doi: 10.1002/humu.10194.
9. Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, Noebels JL, Sweatt JD, Zoghbi HY. 2004. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Human Molecular Genetics 13:2679-2689. doi: 10.1093/hmg/ddh282.
10. del Gaudio D, Fang P, Scaglia F, Ward PA, Craigen WJ, Glaze DG, Neul JL, Patel A, Lee JA, Irons M, Berry SA, Pursley AA, Grebe TA, Freedenberg D, Martin RA, Hsich GE, Khera JR, Friedman NR, Zoghbi HY, Eng CM, Lupski JR, Beaudet AL, Cheung SW, Roa BB. 2006. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genetics in Medicine 8:784-792. doi: 10.1097/01. gim.0000250502.28516.3c.
11. Ebert DH, Gabel HW, Robinson ND, Kastan NR, Hu LS, Cohen S, Navarro AJ, Lyst MJ, Ekiert R, Bird AP, Greenberg ME. 2013. Activity-dependent phosphorylation of MECP2 threonine 308 regulates interaction with NcoR. Nature 499:341-345. doi: 10.1038/nature12348.
12. Free A, Wakefield RID, Smith BO, Dryden DTF, Barlow PN, Bird AP. 2001. DNA Recognition by the methyl-CpG binding domain of MeCP2. Journal of Biological Chemistry 276:3353-3360. doi: 10.1074/jbc.M007224200.
13. Friez MJ, Jones JR, Clarkson K, Lubs H, Abuelo D, Bier J-AB, Pai S, Simensen R, Williams C, Giampietro PF, Schwartz CE, Stevenson RE. 2006. Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics 118:e1687-1695. doi: 10.1542/peds.2006-0395.
14. Guy J, Hendrich B, Holmes M, Martin JE, Bird A. 2001. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nature Genetics 27:322-326. doi: 10.1038/85899.
15. Hagberg B, Aicardi J, Dias K, Ramos O. 1983. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Annals of Neurology 14:471-479. doi: 10.1002/ana.410140412.
16. Klauck SM, Lindsay S, Beyer KS, Splitt M, Burn J, Poustka A. 2002. A mutation hot spot for nonspecific x-linked mental retardation in the MECP2 gene causes the PPM-x syndrome. American Journal of Human Genetics 70:1034-1037. doi: 10.1086/339553.
17. Kudo S, Nomura Y, Segawa M, Fujita N, Nakao M, Schanen C, Tamura M. 2003. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. Journal of Medical Genetics 40:487-493. doi: 10.1136/jmg.40.7.487.
18. Laccone F, Huppke P, Hanefeld F, Meins M. 2001. Mutation spectrum in patients with rett syndrome in the German population: evidence of hot spot regions. Human Mutation 17:183-190. doi: 10.1002/humu.3.
19. Lam C-W, Yeung W-L, Ko C-h, Poon PMK, Tong S-F, Chan K-Y, Lo IFM, Chan LYS, Hui J, Wong V, Pang CP, Lo YM, Fok TF. 2000. Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. Journal of Medical Genetics 37:E1-E4. doi: 10.1136/jmg.37.5.e1.
20. Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A. 1992. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69:906-914. doi: 10.1016/0092-8674(92)90610-O.
21. Li Y, Wang H, Muffat J, Cheng AW, Orlando DA, Lovén J, Kwok S-m, Feldman DA, Bateup HS, Gao Q, Hockemeyer D, Mitalipova M, Lewis CA, Vander Heiden MG, Sur M, Young RA, Jaenisch R. 2013. Global transcriptional and translational repression in human-embryonic-stem-cell-derived rett syndrome neurons. Cell Stem Cell 13:446-458. doi: 10.1016/j.stem.2013.09.001.
22. Lugtenberg D, de Brouwer APM, Kleefstra T, Oudakker AR, Frints SGM, Schrander-Stumpel CTRM, Fryns JP, Jensen LR, Chelly J, Moraine C, Turner G, Veltman JA, Hamel BC, de Vries BB, van Bokhoven H, Yntema HG. 2006. Chromosomal copy number changes in patients with non-syndromic X linked mental retardation detected by array CGH. Journal of Medical Genetics 43:362-370. doi: 10.1136/jmg.2005.036178.
23. Lyst MJ, Ekiert R, Ebert DH, Merusi C, Nowak J, Selfridge J, Guy J, Kastan NR, Robinson ND, de Lima Alves F, Rappsilber J, Greenberg ME, Bird A. 2013. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nature Neuroscience 16:898-902. doi: 10.1038/nn.3434.
24. Meins M, Lehmann J, Gerresheim F, Herchenbach J, Hagedorn M, Hameister K, Epplen JT. 2005. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. Journal of Medical Genetics 42:e12. doi: 10.1136/jmg.2004.023804.
25. Na ES, Nelson ED, Adachi M, Autry AE, Mahgoub MA, Kavalali ET, Monteggia LM. 2012. A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission. Journal of Neuroscience 32:3109-3117. doi: 10.1523/JNEUROSCI.6000-11.2012.
26. Nan X, Campoy FJ, Bird A. 1997. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88:471-481. doi: 10.1016/S0092-8674(00)81887-5.
27. Nan X, Ng H-H, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389. doi: 10.1038/30764.
28. Skene PJ, Illingworth RS, Webb S, Kerr ARW, James KD, Turner DJ, Andrews R, Bird AP. 2010. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Molecular Cell 37:457-468. doi: 10.1016/j.molcel.2010.01.030.
29. Stancheva I, Collins AL, Van den Veyver IB, Zoghbi H, Meehan RR. 2003. A mutant form of MeCP2 protein associated with human rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Molecular Cell 12:425-435. doi: 10.1016/S1097-2765(03)00276-4.
30. Street IH, Shah PK, Smith AM, Avery N, Neff MM. 2008. The AT-hook-containing proteins SOB3/AHL29 and ESC/AHL27 are negative modulators of hypocotyl growth in Arabidopsis. The Plant Journal 54:1-14. doi: 10.1111/j.1365-313X.2007.03393.x.
31. Van Esch H, Bauters M, Ignatius J, Jansen M, Raynaud M, Hollanders K, Lugtenberg D, Bienvenu T, Jensen LR, Gécz J, Moraine C, Marynen P, Fryns JP, Froyen G. 2005. Duplication of the MECP2 region is a Frequent cause of severe mental retardation and progressive neurological symptoms in males. The American Journal of Human Genetics 77:442-453. doi: 10.1086/444549.
32. Wakefield RID, Smith BO, Nan X, Free A, Soteriou A, Uhrin D, Bird AP, Barlow PN. 1999. The Solution structure of the domain from MeCP2 that binds to methylated DNA. Journal of Molecular Biology 291:1055-1065. doi: 10.1006/jmbi.1999.3023.
33. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Research 33:e36. doi: 10.1093/nar/gni035.